183 related articles for article (PubMed ID: 28986187)
1. Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO-1/AMPK pathway in colon cancer cells.
Shukla K; Sonowal H; Saxena A; Ramana KV; Srivastava SK
Cancer Lett; 2017 Dec; 411():57-63. PubMed ID: 28986187
[TBL] [Abstract][Full Text] [Related]
2. Aldose reductase inhibition suppresses colon cancer cell viability by modulating microRNA-21 mediated programmed cell death 4 (PDCD4) expression.
Saxena A; Shoeb M; Ramana KV; Srivastava SK
Eur J Cancer; 2013 Oct; 49(15):3311-9. PubMed ID: 23827854
[TBL] [Abstract][Full Text] [Related]
3. Aldose Reductase Inhibitor Protects against Hyperglycemic Stress by Activating Nrf2-Dependent Antioxidant Proteins.
Shukla K; Pal PB; Sonowal H; Srivastava SK; Ramana KV
J Diabetes Res; 2017; 2017():6785852. PubMed ID: 28740855
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase regulates doxorubicin-induced immune and inflammatory responses by activating mitochondrial biogenesis.
Sonowal H; Saxena A; Qiu S; Srivastava S; Ramana KV
Eur J Pharmacol; 2021 Mar; 895():173884. PubMed ID: 33482179
[TBL] [Abstract][Full Text] [Related]
5. Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells.
Tammali R; Saxena A; Srivastava SK; Ramana KV
J Biol Chem; 2011 Jul; 286(27):24089-100. PubMed ID: 21576240
[TBL] [Abstract][Full Text] [Related]
6. Aldose reductase inhibition suppresses azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice.
Saxena A; Shoeb M; Tammali R; Ramana KV; Srivastava SK
Cancer Lett; 2014 Dec; 355(1):141-7. PubMed ID: 25218594
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of aldose reductase prevents growth factor-induced G1-S phase transition through the AKT/phosphoinositide 3-kinase/E2F-1 pathway in human colon cancer cells.
Ramana KV; Tammali R; Srivastava SK
Mol Cancer Ther; 2010 Apr; 9(4):813-24. PubMed ID: 20354121
[TBL] [Abstract][Full Text] [Related]
8. Aldose reductase inhibitor increases doxorubicin-sensitivity of colon cancer cells and decreases cardiotoxicity.
Sonowal H; Pal PB; Wen JJ; Awasthi S; Ramana KV; Srivastava SK
Sci Rep; 2017 Jun; 7(1):3182. PubMed ID: 28600556
[TBL] [Abstract][Full Text] [Related]
9. Aldose Reductase Inhibitor, Fidarestat Prevents High-fat Diet-induced Intestinal Polyps in Apc
Saxena A; Tammali R; Ramana KV; Srivastava SK
Curr Cancer Drug Targets; 2018; 18(9):905-911. PubMed ID: 28786349
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase inhibitor, fidarestat prevents doxorubicin-induced endothelial cell death and dysfunction.
Sonowal H; Pal P; Shukla K; Saxena A; Srivastava SK; Ramana KV
Biochem Pharmacol; 2018 Apr; 150():181-190. PubMed ID: 29458045
[TBL] [Abstract][Full Text] [Related]
11. Aldose reductase regulates hyperglycemia-induced HUVEC death via SIRT1/AMPK-α1/mTOR pathway.
Pal PB; Sonowal H; Shukla K; Srivastava SK; Ramana KV
J Mol Endocrinol; 2019 Jul; 63(1):11-25. PubMed ID: 30986766
[TBL] [Abstract][Full Text] [Related]
12. Aldose reductase inhibition enhances TRAIL-induced human colon cancer cell apoptosis through AKT/FOXO3a-dependent upregulation of death receptors.
Shoeb M; Ramana KV; Srivastava SK
Free Radic Biol Med; 2013 Oct; 63():280-90. PubMed ID: 23732517
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of aldose reductase prevents colon cancer metastasis.
Tammali R; Reddy AB; Saxena A; Rychahou PG; Evers BM; Qiu S; Awasthi S; Ramana KV; Srivastava SK
Carcinogenesis; 2011 Aug; 32(8):1259-67. PubMed ID: 21642355
[TBL] [Abstract][Full Text] [Related]
14. Aldose Reductase Inhibitor Fidarestat as a Promising Drug Targeting Autophagy in Colorectal Carcinoma: a Pilot Study.
Pandey S
Asian Pac J Cancer Prev; 2015; 16(12):4981-5. PubMed ID: 26163626
[TBL] [Abstract][Full Text] [Related]
15. [Ginsenoside Re regulates mitochondrial biogenesis through Nrf2/HO-1/PGC-1α pathway to reduce hypoxia/reoxygenation injury in H9c2 cells].
Xin GJ; Chen YY; Liu ZX; Xu SJ; Zhang HY; Guo F; Peng H; Li L; Han X; Liu JX; Fu JH
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1064-1072. PubMed ID: 38621913
[TBL] [Abstract][Full Text] [Related]
16. Cilostazol attenuates murine hepatic ischemia and reperfusion injury via heme oxygenase-dependent activation of mitochondrial biogenesis.
Joe Y; Zheng M; Kim HJ; Uddin MJ; Kim SK; Chen Y; Park J; Cho GJ; Ryter SW; Chung HT
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G21-9. PubMed ID: 25951827
[TBL] [Abstract][Full Text] [Related]
17. Aldose reductase regulates growth factor-induced cyclooxygenase-2 expression and prostaglandin E2 production in human colon cancer cells.
Tammali R; Ramana KV; Singhal SS; Awasthi S; Srivastava SK
Cancer Res; 2006 Oct; 66(19):9705-13. PubMed ID: 17018629
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase inhibition prevents colon cancer growth by restoring phosphatase and tensin homolog through modulation of miR-21 and FOXO3a.
Saxena A; Tammali R; Ramana KV; Srivastava SK
Antioxid Redox Signal; 2013 Apr; 18(11):1249-62. PubMed ID: 22978663
[TBL] [Abstract][Full Text] [Related]
19. Activation of mitochondrial biogenesis by heme oxygenase-1-mediated NF-E2-related factor-2 induction rescues mice from lethal Staphylococcus aureus sepsis.
MacGarvey NC; Suliman HB; Bartz RR; Fu P; Withers CM; Welty-Wolf KE; Piantadosi CA
Am J Respir Crit Care Med; 2012 Apr; 185(8):851-61. PubMed ID: 22312014
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin induces heme oxygenase-1 via NF-E2-related factor 2 (Nrf2) activation through ERK and PI3K/Akt pathway in colon cancer.
Jang HJ; Hong EM; Kim M; Kim JH; Jang J; Park SW; Byun HW; Koh DH; Choi MH; Kae SH; Lee J
Oncotarget; 2016 Jul; 7(29):46219-46229. PubMed ID: 27323826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
